Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring
Hypertension is associated with structural and functional changes in blood vessels with increased arteriosclerosis, vascular inflammation, and endothelial dysfunction. Decreased adherence (compliance) to antihypertensive medications contributes significantly to morbidity and mortality in hypertensiv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558620/ https://www.ncbi.nlm.nih.gov/pubmed/37810167 http://dx.doi.org/10.1016/j.heliyon.2023.e19467 |
_version_ | 1785117318182862848 |
---|---|
author | Mobed, Ahmad Gholami, Sarah Tahavvori, Amir Ghazi, Farhood Masoumi, Zahra Alipourfard, Iraj Naderian, Ramtin Mohammadzadeh, Mehran |
author_facet | Mobed, Ahmad Gholami, Sarah Tahavvori, Amir Ghazi, Farhood Masoumi, Zahra Alipourfard, Iraj Naderian, Ramtin Mohammadzadeh, Mehran |
author_sort | Mobed, Ahmad |
collection | PubMed |
description | Hypertension is associated with structural and functional changes in blood vessels with increased arteriosclerosis, vascular inflammation, and endothelial dysfunction. Decreased adherence (compliance) to antihypertensive medications contributes significantly to morbidity and mortality in hypertensive patients. Antihypertensive drugs (AHTDs) and lifestyle changes are the main cornerstones for treating hypertension. Several approaches have been described in the literature for determining AHTDs based on different analytical techniques. Amongst biosensors are one of the most attractive tools due to their inherent advantages. Biosensors are used for the detection of wide range of biomarkers as well as different drugs in past two decades. The main focus of the present study is to review the latest biosensors developed for the detection of AHTDs. Readers of the present study will be able to familiarize themselves with biosensors as advanced and modern diagnostic tools while reviewing the most widely used AHTDs. In the present study, the routine methods are first reviewed and while examining their advantages and disadvantages, biosensors have been introduced as ideal alternative tools. |
format | Online Article Text |
id | pubmed-10558620 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-105586202023-10-08 Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring Mobed, Ahmad Gholami, Sarah Tahavvori, Amir Ghazi, Farhood Masoumi, Zahra Alipourfard, Iraj Naderian, Ramtin Mohammadzadeh, Mehran Heliyon Review Article Hypertension is associated with structural and functional changes in blood vessels with increased arteriosclerosis, vascular inflammation, and endothelial dysfunction. Decreased adherence (compliance) to antihypertensive medications contributes significantly to morbidity and mortality in hypertensive patients. Antihypertensive drugs (AHTDs) and lifestyle changes are the main cornerstones for treating hypertension. Several approaches have been described in the literature for determining AHTDs based on different analytical techniques. Amongst biosensors are one of the most attractive tools due to their inherent advantages. Biosensors are used for the detection of wide range of biomarkers as well as different drugs in past two decades. The main focus of the present study is to review the latest biosensors developed for the detection of AHTDs. Readers of the present study will be able to familiarize themselves with biosensors as advanced and modern diagnostic tools while reviewing the most widely used AHTDs. In the present study, the routine methods are first reviewed and while examining their advantages and disadvantages, biosensors have been introduced as ideal alternative tools. Elsevier 2023-08-27 /pmc/articles/PMC10558620/ /pubmed/37810167 http://dx.doi.org/10.1016/j.heliyon.2023.e19467 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Mobed, Ahmad Gholami, Sarah Tahavvori, Amir Ghazi, Farhood Masoumi, Zahra Alipourfard, Iraj Naderian, Ramtin Mohammadzadeh, Mehran Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
title | Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
title_full | Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
title_fullStr | Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
title_full_unstemmed | Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
title_short | Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
title_sort | nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558620/ https://www.ncbi.nlm.nih.gov/pubmed/37810167 http://dx.doi.org/10.1016/j.heliyon.2023.e19467 |
work_keys_str_mv | AT mobedahmad nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT gholamisarah nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT tahavvoriamir nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT ghazifarhood nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT masoumizahra nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT alipourfardiraj nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT naderianramtin nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring AT mohammadzadehmehran nanosensorsinthedetectionofantihypertensiondrugsagoldenstepformedicationadherencemonitoring |